Chimerix investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of chimerix, inc. - cmrx

New york & new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of chimerix, inc. (nasdaqgm: cmrx) to jazz pharmaceuticals plc. (nasdaqgs: jazz). under the terms of the proposed transaction, shareholders of chimerix will receive $8.55 in cash for each share of chimerix that they own. ksf is seeking to determine whether this consideration and the process that led to.
GM Ratings Summary
GM Quant Ranking